Announcements Trials
Browse Landscape

Status

Completed 9Recruiting 7Unknown 3Terminated 3Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 5Genitourinary 5Other neoplasm 3Lymphoid 3Breast 3Tumor-Agnostic 2Head & Neck 2Gastrointestinal 2Sarcoma 1Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Other 1Gynecologic 1Dermatologic 1CNS 1

Conditions

Sarcoma 1

Interventions

Cyclophosphamide 9Radiotherapy 8Temozolomide 6Magnetic Resonance Spectroscopy 6Filgrastim 6Doxorubicin 6pazopanib 5Gemcitabine 5pembrolizumab 4Vincristine 4Radiation 4Etoposide 4Docetaxel 4Carboplatin 4Biopsy 4Trabectedin 3Taxes 3Specimen Handling 3Paclitaxel 3Nivolumab 3Irinotecan 3Drug Therapy 3olaparib 2niraparib 2liposomal doxorubicin 2fludarabine phosphate 2fludarabine 2brigimadlin 2Trastuzumab 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Surveys and Questionnaires × Sarcoma × Clear all
NCT00508339 2012-08-01

Functional Outcomes Following Limb Sparing Surgery for Sarcoma Patients

M.D. Anderson Cancer Center

Withdrawn
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡